Extracorporeal Membrane Oxygenation in Cardiogenic Shock due to Acute Myocardial Infarction: A Systematic Review

Table 3

Comorbidities associated with the use of ECMO.

Study	Year	Country	Design	Year of follow-up	Follow-up	N	Type of ECMO	Age (years)	Gender	Comorbidities
Negi et al. [17]	20 15	USA	Retrospective	NA	NA	16	V-A ECMO	NA	NA	Diabetes
Chang et al. [18]	20 16	Taiwan	Retrospective	12.2002-12.2012	2.89 months	17 05	V-A ECMO	y	70.6% male	Diabetes; Hypertension; Cerebral vascular disease; Cardiovascular disease; Chronic kidney disease Chronic liver disease Hyperlipidaemia; Cancer; Gastric ulcer
Wu et al. [19]	20 13	China	Retrospective	06.2003-12.2011	12 months (169)	35	V-A ECMO	65.5 y	77.5% male	Diabetes mellitus; mg/dl Chronic dialysis; Previous PCI; Previous AMI; Previous stroke
Chou et al. [20]	2013	Taiwan	Retrospective	01.2006- 07.2010	12 mo	43	V-A ECMO	60.525 y	93%	Hypertension; Diabetes Stroke Chronic lung insufficiency; Previous heart disease
Huang et al. [21]	2017	China	Retrospective	01.2009–01.2015	30 days	20	V-A ECMO	y	85% male	Hypertension; Diabetes; Old myocardial infarction; Active smoke
Sando val et al. [22]	2015	USA	Retrospective	NA	1 mo	21	V-A ECMO	62 y	62% male	History of coronary artery disease; Prior myocardial infarction; Diabetes
Guent her et al. [23]	2013	Germany	Retrospective	02.2012-08.2013	30 days	23	V-A ECMO	y	15% female	NA
Jeon et al. [24]	2018	South Korea	Retrospective	01.2006-12.2016	12 mo	108	V-A ECMO	y	NA	NA
Fu HX et al. [26]	2017	China	Retrospective	01.2014- 03.2017	NA	27	V-A ECMO	NA	NA	NA

V-A ECMO: venoarterial extracorporeal membrane oxygenation; PCI: percutaneous coronary intervention; AMI: acute myocardial infarction.